Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

Virtual Journal Clubs & Case Studies – Engaging Your Advisors Creatively

Creatively engage your advisors while deepening medical understanding! Dive into virtual journal clubs and case studies to analyze patient scenarios, dissect new research, and gain critical feedback on your brand...

Impetus Digital

Biogen Idec building

Biogen and City Therapeutics to develop RNAi therapies in deal worth over $1bn

The partners will focus on a target that mediates key central nervous system diseases

- PMLiVE

Sanofi gains access to Alzheimer’s candidate through $470m Vigil acquisition

A phase 2 trial of the drug is expected to launch in the third quarter of this year

- PMLiVE

The future of customer engagement in biopharma

By Aaron Bean

- PMLiVE

J&J’s Darzalex Faspro recommended by FDA panel of experts for smouldering multiple myeloma

The early precursor of active multiple myeloma accounts for around 15% of all new cases

- PMLiVE

Merck shares promising phase 3 results for Keytruda in ovarian cancer

Approximately 20,890 cases of the disease are expected to be diagnosed in the US this year

- PMLiVE

Improving engagement with clinical trials: time to apply behavioural science

By Rob Horne

- PMLiVE

Bristol Myers Squibb’s perioperative Opdivo regimen granted EC approval in NSCLC

Up to 55% of patients with non-metastatic NSCLC develop recurrence despite curative resection

- PMLiVE

Boehringer’s nerandomilast shows lung function benefit in phase 3 IPF and PPF trials

The candidate is currently under review for both interstitial lung diseases in the EU and US

- PMLiVE

Exploring AI in pharma: how can we achieve lift-off?

By Alex Legg and James Turnbull

- PMLiVE

BioNTech announces £1bn UK investment to boost regional R&D presence

The UK government has also agreed to award the company a grant of up to £129m

- PMLiVE

Researchers uncover promising treatment approach for inherited breast cancer

The study evaluated chemotherapy followed by a targeted cancer drug in patients before surgery

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links